NCT02648659View on ClinicalTrials.gov

The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 2, 2016

Primary Completion Date

January 6, 2017

Study Completion Date

February 14, 2017

Conditions

Peptic Ulcer

Interventions

DRUG

Ilaprazole

Ilaprazole 10mg 1tablet qid(4 times/day)

DRUG

Amoxicillin

Amoxicillin 500mg 1capsule qid(4times/day)

DRUG

Clarithromycin

Clarithromycin 500mg 1tablet bid(2times/day)

DRUG

Metronidazole

Metronidazole 250mg 2tablets tid(3times/day)

All Listed Sponsors

lead

Kyungpook National University Hospital

OTHER

NCT02648659 - The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients | Biotech Hunter | Biotech Hunter